<DOC>
	<DOCNO>NCT01677663</DOCNO>
	<brief_summary>Autism autism spectrum disorder ( ASD ) relatively common ( 0.3 % Taiwan ) , multi-factorial , genetically clinically heterogeneous , childhood-onset neurodevelopmental disorder . Due high heritability severe long-term impairment without available laboratory diagnosis , effective prevention treatment , disastrous disease prioritize molecular genetic study . Recent CNVs investigation identify rare variant GWA study endophenotype approach promise strategy identify common genetic variant . In addition intermediate phenotype head circumstance , speech delay , social impairment stereotype behavior , evidence demonstrate neuropsychology neuroimages may useful endophenotypes autism . Dlgap2 , Fbxo25 , Arhgef10 knoutout mouse generate previous CNV result characterize .</brief_summary>
	<brief_title>Neuropsychopathological Study Autism</brief_title>
	<detailed_description>The specific aim study aree : 1 . To collect complete environmental , developmental , clinical , neuropsychological , genetic data 350 probands autism ( 800 total , 450 [ 96HD008 ] ) family ; 2 . To re-sequence promoter region , exon , 3'UTR region DLGAP2 , CLN8 , ARHGEF10 , FBXO25 , GABRB3 gene ( one gene per year ) ; 3 . To conduct fine-mapping replication study select candidate gene GWA study [ 96HD008 ] ; 4 . To validate social impairment speech delay intermediate phenotype executive function effective cognitive endophenotypes first demonstrate difference measure among probands , unaffected sibling neurotypicals , follow different genetic risk ( e.g. , neurexin , neuroligin , CNTNAP2 , SHANK3 , MET , PTEN , WNT2 , FOXP2 , DLGAP2 , CLN8 , ARHGEF10 , FBXO25 , GABRB3 ) ; 5 . To validate structural functional connectivity effective imaging endophenotypes demonstrate difference probands autism , sibling , match neurotypicals ; 6 . To characterize phenotype explore possible function autism-related gene find use GWAS , explore possible drug target treatment Dlgap2 , Fbxo25 , Arhgef10 mutant mouse . The investigator recruit 350 probands clinical diagnosis autism confirm ADI-R ADOS , family . The probands sibling also assess psychiatric disorder ( K-SADS-E ) ; autistic symptom dimension ( SRS , SCQ , CAST , ABC ) , behavioral symptom ( CBCL , SNAP-IV ) , perinatal/environmental risk factor . The direct test include intelligence ( CPM/SPM , WISC-III , WPPSI-R ) neuropsychological test ( CPT , WCST , CANTAB ) . The parent assess DSM-IV psychiatric disorder ( ASRI-4 ) autistic feature ( AQ , SRS ) . The investigator collect blood sample subject . Probands previous CNVs finding ( n = 20 ) high-functioning autism ( n=30 ) receive MRI assessment ( Diffusion Spectrum Imaging , resting-state fMRI ) compare 50 age- , sex- , handedness-matched neurotypicals . The investigator ( 1 ) characterize behavioral , structural , electrophysiological biochemical phenotype Dlgap2 , Arhgef10 mice 4 week , 8 week , 12 week 16 week age ; ( 2 ) explore possible function autism-related gene find GWAS analysis ; ( 3 ) explore possible drug target treatment autism KO mouse . While potential target recognize , exist compound target test . The investigator anticipate establish representative cohort 800 patient autism family study [ 96HD008 ] comprehensive clinical genetic data . This well-characterized cohort contribute validation intermediate phenotype cognitive image endophenotypes autism study , use search rare variant CNVs analysis common variant GWAS analysis future study , pave way 2-3 line well-characterized transgenic animal model autism ( e.g. , Dlgap2 ) . In addition , wealth data cohort benefit current future investigation autism basis future international collaboration . The investigator also anticipate publication 20 SCI paper ( 4 per year ) presentation work peer-reviewed scientific conference 40 poster oral communication .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>subject clinical diagnosis autistic disorder Asperger disorder define DSMIV ICD10 ; age range 3 25 conduct study ; subject least one biological parent ; parent subject Han Chinese ; subject biological parent ( sibling ) consent participate study . currently meet criterion history DSMIV Schizophrenia , Schizoaffective Disorder , Organic Psychosis .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>autism</keyword>
	<keyword>clinical phenotype</keyword>
	<keyword>neuropsychology</keyword>
	<keyword>image endophenotypes</keyword>
	<keyword>family-based cohort</keyword>
	<keyword>knoutout mouse</keyword>
</DOC>